|
Accueil > Actualité
Novo Nordisk: shares down after UBS downgrade
(CercleFinance.com) - The Novo Nordisk share is down 0.
3% at 389.2 Danish kronor in morning trading on Monday, after UBS downgraded the world's biggest producer of diabetes drugs to "neutral." "Novo is up 32% this year and consensus growth estimates are now in-line with ours," the broker wrote in a note to clients. "There are many reasons to like the fundamentals but it is time for a breather," it added. Copyright (c) 2019 CercleFinance.com. All rights reserved. |
19/04/2024 10:50
Econocomconfirme une hausse du CA comprise entre 3 et 5% 19/04/2024 10:42 Umicoreles obligations durables placées avec succès 19/04/2024 10:30 Keyruscroissance de 5,2% du chiffre d'affaires 19/04/2024 10:25 Capgeminiune nouvelle plateforme mise en place pour Bayer 19/04/2024 10:14 Renaultun nouveau concept 'compact' de point de vente 19/04/2024 10:03 Believea rendu un avis favorable sur l'offre d'achat Tous les articles sociétés |
